Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Collinson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2019
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of TocilizumabJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Future Virology|November 6, 2023
Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY)Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptorGregori J Morriello, Gary Chicchi, Tricia Johnson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2002
Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptorNeil Collinson, Frederick M Kuenzi, Wolfgang Jarolimek, et al.
Plos Pathogens|May 6, 2021
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret modelLeo Y Lee, Jie Zhou, Paulina Koszalka, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonistsGregori J Morriello, Sander G Mills, Tricia Johnson, et al.
Plos Pathogens|April 16, 2020
Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmissionLeo Yi Yang Lee, Jie Zhou, Rebecca Frise, et al.
Journal of Medicinal Chemistry|April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancersFrancine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2019
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of TocilizumabJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Future Virology|November 6, 2023
Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY)Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptorGregori J Morriello, Gary Chicchi, Tricia Johnson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2002
Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptorNeil Collinson, Frederick M Kuenzi, Wolfgang Jarolimek, et al.
Plos Pathogens|May 6, 2021
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret modelLeo Y Lee, Jie Zhou, Paulina Koszalka, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonistsGregori J Morriello, Sander G Mills, Tricia Johnson, et al.
Plos Pathogens|April 16, 2020
Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmissionLeo Yi Yang Lee, Jie Zhou, Rebecca Frise, et al.
Journal of Medicinal Chemistry|April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancersFrancine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Pageof 3